Masimo Story

<div class='circular--portrait' style='background:#FF0000;color: #F5FFFA;font-size:3em;'>MAS</div>
MASI -- USA Stock  

USD 225.90  7.95  3.65%

As many of us are excited about healthcare space, it is fair to concentrate on Masimo within current market trends. As expected, Masimo is starting to reaffirm its true potential as stockholders are becoming more and more confident in the future outlook. The returns on investing in Masimo and the market returns of the last few months appear not related. The occurrence of stable primary indicators of the company implies a mid-run price swing for stockholders of Masimo. Masimo is scheduled to announce its earnings today. The next earnings report is expected on the 4th of November 2020.
Published over two months ago
View all stories for Masimo | View All Stories
Will Masimo (NASDAQ:MASI) price continue to rise in August?
Masimo's average rating is Buy from 4 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Masimo market sentiment investors' perception of the future value of Masimo. Let us look at a few aspects of Masimo technical analysis. The company has Profit Margin (PM) of 21.66 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 26.46 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.26.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Masimo. In general, we focus on analyzing Masimo stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Masimo's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Masimo's intrinsic value. In addition to deriving basic predictive indicators for Masimo, we also check how macroeconomic factors affect Masimo price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.

How does Masimo Stands against Peers?

Analyzing Masimo competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Masimo across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Masimo Competition Details

How Masimo utilizes its cash?

To perform a cash flow analysis of Masimo, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Masimo is receiving and how much cash it distributes out in a given period. The Masimo cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Masimo Net Cash Flow from Operations is most likely to increase significantly in the upcoming years. The last year's value of Net Cash Flow from Operations was reported at 419.12 Million

Exercise or conversion by Jon Coleman of 1250 shares of Masimo subject to Rule 16b-3

Legal trades by Masimo insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Masimo insider trading alert for exercise of non-qualified stock option (right to buy) by Jon Coleman, Pres-WW SalesPro SvcMed Affs, on 8th of July 2020. This event was filed by Masimo Corp with SEC on 2020-07-08. Statement of changes in beneficial ownership - SEC Form 4. Jon Coleman currently serves as president - worldwide sales, professional services and medical affairs of Masimo [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Closer look at Masimo Semi Variance

Masimo has current Semi Variance of 5.09. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.

Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Variance 
 = 
SUM(RET DEV)2 
N(ZERO) 
 = 
5.09
SUM = Summation notation
RET DEV = Actual return deviation over selected period
N(ZERO) = Number of points with returns less than zero
Let's now compare Masimo Semi Variance to its closest peers:
MASI
ECOR
EKSO
ALC
BDX
MASI5.088319631243742
ECOR30.18
EKSO42.95
ALC3.71
BDX5.87

Momentum Analysis of Masimo suggests possible reversal in August

Current standard deviation is at 2.42. As of the 28th of July, Masimo secures the Mean Deviation of 1.97, downside deviation of 2.44, and Risk Adjusted Performance of 0.1921. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Masimo, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have collected data for nineteen technical drivers for Masimo, which can be compared to its peers in the industry. Please verify Masimo information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Masimo is priced some-what accurately, providing market reflects its recent price of 235.71 per share. Given that Masimo has jensen alpha of 0.2568, we recommend you to check Masimo's last-minute market performance to make sure the company can sustain itself at a future point.

Our Final Take On Masimo

While many of the other players within the medical instruments & supplies industry are still a little expensive, even after the recent corrections, Masimo may offer a potential longer-term growth to stockholders. With an impartial outlook on the current market volatility, it may be better to hold off any inventment activity and neither pick up nor drop any shares of Masimo at this time. The Masimo risk-reward trade off is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Masimo.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Masimo. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com